Trial intelligence / Profile preview

TAS-102 + Fruquintinib ± Chidamide + Serplulimab in third-line and beyond metastatic colorectal cancer

ChiCTR2500115578Phase 4Not yet recruiting

Sponsor

First Affiliated Hospital of Soochow University

Start

Dec 2025

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1